UBS Group »

Briacell Therapeutics Corp shares owned by UBS Group

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTXW) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Briacell Therapeutics Corp

Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 202405k10k010k20k30k
Value ($)Share countHistorical BCTXW position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by UBS Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $12k 29k 0.41
2024-06-30 $2.7k 10k 0.27
2023-09-30 $350 142 2.47
2022-12-31 $3.0k 1.4k 2.06
2022-09-30 $8.0k 2.9k 2.73
2022-06-30 $13k 5.1k 2.56
2022-03-31 $6.0k 1.1k 5.28
2021-09-30 $10k 2.1k 4.80

Top funds holding Briacell Therapeutics Corp